Exercise May Decrease Cancer Incidences, Rate Of Tumor Growth

While exercise can help prevent health issues like diabetes and cardiovascular disease, it may also decrease instances of cancer and slow the growth rate of tumors.

According to a new study conducted by researchers at the University of Copenhagen, mice that trained regularly on a wheel experienced a reduction in the growth of cancerous skin, liver and lung tumors. Mice that exercised frequently also had a smaller chance of developing cancer.

Researchers claimed that the positive effects of exercise also extended to cancer-associated weight loss known as cachexia. Cachexia - a weakening of the body due to chronic illness - was not experienced by the mice in the exercise group.

Effects of exercise

Researchers believe they have discovered the factors behind the anti-tumor effects of regular exercise. They claim that adrenaline - a hormone critical to the fight-or-flight response - is produced by the stimulation of exercise.

The study puts forth that the production of adrenaline causes immune cells to assemble. One specific immune cell, called the Natural Killer (NK), safeguards the body by attacking the site of tumors. After infiltrating the tumor, NK can slow down or completely prevent its growth.

Researchers concluded the study by emphasizing not only the positive health benefits of daily exercise, but also the utilization of NK cells as a possible strategy for slowing the growth of multiple tumors.

Source: American Society for Cell Biology

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap